The inaugural TTP Cambridge Cell & Gene Summit aims to bring together the exciting developments within the UK Innovation Corridor between Cambridge, Stevenage and London, and to bring back some ‘normality’ for the community to meet after more than a year of no face-to-face contact. The event will take place from 13:30-19:00 on Wednesday 15 September on Melbourn Science Park.
Join the Missouri Cures Education Foundation from noon to 1 pm on May 6th for a virtual panel discussion via Zoom. Regenerative Medicine is at the forefront of medical research. Join our expert panelists as they discuss using groundbreaking technologies to find therapies and cures.
Successful reconstruction of CranioMaxillofacial (CMF) bones due to congenital malformations, tumor and/or trauma remains a major challenge. From a materials perspective, the pillars for the development of strategies for CMF bone regeneration have included electrospinning and 3D (bio)printing technologies. This presentation will discuss the latest innovations in the field and provide future directions to expedite clinical translation.
Regenerative medicines—gene, cell, and tissue therapies—are widely seen as the future of pharmaceuticals. Yet the greater biological complexity of these products has led to new regulatory challenges. Legislators and regulators have developed new policies and procedures to help facilitate the review, approval, and reimbursement of these medicines, including the Regenerative Medicine Advanced Therapy (RMAT) designation in the U.S. They have also interpreted how existing laws, such as the regulations that govern orphan products, apply to these new technologies. But many challenges remain—including the threat of increased enforcement—and this area continues to hold special interest for life sciences companies.
Please join Covington’s Life Sciences lawyers for our first session of the Regenerative Medicine Webinar Series to discuss the regulation of the products in the U.S., Europe, and China.
Connext brings together pharma, biotech and cell & gene companies who use Werum PAS-X MES as well as those who are interested in the use of manufacturing IT and manufacturing intelligence to digitize their production. For the first time, our meeting will take place as a virtual online event under the joint Körber brand. Accommodations have been made for different time zones in Asia, Europe and the US.
Join our live web seminar on “Digitally transforming manufacturing to build trust across the value network” on 24 February 2021 at 11 AM ET, held by Join David Smith, Vice President Technical Operations at Ori Biotech North America, Gary Leonard, Group Operations Director at SteriPack, and Daniel Matlis, President at Axendia.
The Immuno-Oncology 360˚Summit (IO360°) will take place virtually, February 23-26, 2021. IO360° convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.
Reporting on the Latest Cell & Gene Therapy Progress with a Focus on Solid Tumors
Cell & Gene Therapy Day convenes stakeholders spanning the science and business communities to report on the latest cell and gene therapy progress to fight a wider range of cancers beyond hematologic malignancies.
